Katherine V Williams

Dr. Katherine V Williams

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
KWKatherine V Williams
Katherine V Williams
KYKevin Yen
Kevin Yen
TOTrevor J. Orchard
Trevor J. Orchard
TCTina Costacou
Tina Costacou


12 February 2025 in Journal of Infection
Verified
Journal Article
Open access
KWKatherine V Williams
Katherine V Williams
MKMary G. Krauland
Mary G. Krauland
MNMary Patricia Nowalk
Mary Patricia Nowalk
LHLee H. Harrison
Lee H. Harrison
JWJohn V. Williams
John V. Williams
RZRichard K. Zimmerman
Richard K. Zimmerman
Availability of caregiver-administered nasal spray live attenuated influenza vaccine (LAIV) raises the potential for increased influenza vaccine uptake. Direct and indirect benefits (decreased influenza cases and hospitalizations) of increased uptake among school-age children may be realized across the age spectrum. We used an agent-based model to determine the extent to which increased vaccination of children might affect overall influenza epidemiology. The Framework for Reproducing Epidemiological Dynamics (FRED) uses a population based on the US census and accounts for individual characteristics to estimate the effect of changes in parameters including vaccine uptake, on outcomes. We modeled increases in vaccine uptake among school-age children 5-17 years old on influenza cases and hospitalizations by age group. Increasing vaccination rates in school-aged children by 5%-15% decreased their symptomatic influenza cases by 3.2%-10.9%, and among all age groups by 3.3%-11.6%, corresponding to an estimated annual reduction in cases of 522,867-1,810,170 among school-age children and of 1,394,687-4,945,952 overall. Annual U.S. hospitalizations could decrease by as much as 49,977, with the greatest impact (23,258) in those ages 65 years and over. The opportunity to increase vaccination coverage in school-age children using LAIV can have a positive impact across all ages.

26 October 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
KWKatherine V Williams
Katherine V Williams
MKMary Krauland
Mary Krauland
LHLee H. Harrison
Lee H. Harrison
JWJohn V Williams
John V Williams
MRMark S. Roberts
Mark S. Roberts
RZRichard Zimmerman
Richard Zimmerman
Older adults (age ≥ 65) are at high risk of influenza morbidity and mortality. This study evaluated the impact of a hypothetical two-dose influenza vaccine regimen per season to reduce symptomatic flu cases by providing preseason (first dose) and mid-season (second dose) protection to offset waning vaccine effectiveness (VE). The Framework for Reconstructing Epidemiological Dynamics (FRED), an agent-based modeling platform, was used to compare typical one-dose vaccination to a two-dose vaccination strategy. Primary models incorporated waning VE of 10% per month and varied influenza season timing (December through March) to estimate cases and hospitalizations in older adults. Additional scenarios modeled reductions in uptake and VE of the second dose, and overall waning. In seasons with later peaks, two vaccine doses had the largest potential to reduce cases (14.4% with February peak, 18.7% with March peak) and hospitalizations (13.1% with February peak, 16.8% with March peak). Reductions in cases and hospitalizations still resulted but decreased when 30% of individuals failed to receive a second dose, second dose VE was reduced, or overall waning was reduced to 7% per month. Agent-based modeling indicates that two influenza vaccine doses could decrease cases and hospitalizations in older individuals. The highest impact occurred in the more frequently observed late-peak seasons. The beneficial impact of the two-dose regimen persisted despite model scenarios of reduced uptake of the second dose, decreased VE of the second dose, or overall VE waning.

14 September 2020 in Diabetologia
Verified
Journal Article
Closed access
PDF file
KWKatherine V Williams
Katherine V Williams
CSChristina M. Shay
Christina M. Shay
JPJulie C. Price
Julie C. Price
BGBret H. Goodpaster
Bret H. Goodpaster
CKCarol A. Kelley
Carol A. Kelley
TOTrevor J. Orchard
Trevor J. Orchard

1 February 2025 in American Journal of Public Health
Verified
Journal Article
Closed access
KWKatherine V Williams
Katherine V Williams
MKMary Krauland
Mary Krauland
LHLee H. Harrison
Lee H. Harrison
JWJohn V Williams
John V Williams
MRMark S. Roberts
Mark S. Roberts
RZRichard Zimmerman
Richard Zimmerman
Objectives. To estimate the effect of influenza vaccination disparities. Methods. We compared symptomatic influenza cases between Black and White races in 2 scenarios: (1) race- and age-specific vaccination coverage and (2) equal vaccination coverage. We also compared differences in household composition between races. We used the Framework for Reconstructing Epidemiological Dynamics, an agent-based model that assigns US Census‒based age, race, households, and geographic location to agents (individual people), in US counties of varying racial and age composition. Results. Influenza cases were highest in counties with higher proportions of children. Cases were up to 30% higher in Black agents with both race-based and race-equal vaccination coverage. Compared with corresponding categories of White households, cases in Black households without children were lower and with children were higher. Conclusions. Racial disparities in influenza cases persisted after equalizing vaccination coverage. The proportion of children in the population contributed to the number of influenza cases regardless of race. Differences in household composition may provide insight into racial differences and offer an opportunity to improve vaccination coverage to reduce influenza burden for both races. ( Am J Public Health. 2025;115(2):209–216. https://doi.org/10.2105/AJPH.2024.307878 )